JonathanEdwardTammelaMD

Obstetrics & Gynecology • Santa Maria, CA

Gynecologic Oncology, Hospice & Palliative Medicine

Physician

Join to view full profile

Are you Dr. Tammela?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 44 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
1325 E Church St Ste 202
Santa Maria, CA 93454
Phone+1 805-346-3456

Fax+1 805-346-3454
Is this information wrong?

Summary

Dr. Jonathan Tammela, MD is an obstetrician/gynecologist in Santa Maria, California. He is currently licensed to practice medicine in California, Wisconsin, and New York. He is affiliated with Mercy Hospital Downtown.

Education & Training

University at BuffaloFellowship, Gynecologic Oncology, 2002 - 2005
University of Florida College of Medicine JacksonvilleResidency, Obstetrics and Gynecology, 1998 - 2002
Indiana University School of MedicineClass of 1998

Certifications & Licensure

CA State Medical License 2018 - 2025
WI State Medical License 2005 - 2019
FL State Medical License 1999 - 2007
NY State Medical License 2002 - 2007
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer Start of enrollment: 2008 Feb 25
Active, not recruiting
Phase 2
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
Active, not recruiting
Phase 3
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
Recruiting
Phase 3
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer Start of enrollment: 2009 Apr 01
Completed
Phase 3
Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Start of enrollment: 2010 Dec 13
Completed
Phase 2
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer Start of enrollment: 2009 Jun 29
Active, not recruiting
Phase 3
Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Start of enrollment: 2010 Jan 19
Active, not recruiting
Not Applicable
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors Start of enrollment: 2010 Feb 08
Active, not recruiting
Phase 2
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy Start of enrollment: 2010 Apr 01
Completed
Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer Start of enrollment: 2010 Oct 12
Active, not recruiting
Phase 3
Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer Start of enrollment: 2011 Oct 01
Completed
Phase 2
Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer Start of enrollment: 2014 Mar 17
Active, not recruiting
Phase 2, Phase 3
Join now to see all

Publications & Presentations

PubMed

16 citations
Characterization of a Putative Ovarian Oncogene, Elongation Factor 1α, Isolated by Panning a Synthetic Phage Display Single-Chain Variable Fragment Library with Cultur...
Sameer Sharma, Jonathan Tammela, Xinhui Wang, Hilal Arnouk, Deborah L. Driscoll, Paulette Mhawech-Fauceglia, Shashikant Lele, A. Latif Kazim, Kunle Odunsi> ;Clinical Cancer Research. 2007 Oct 1
30 citations
OY-TES-1 expression and serum immunoreactivity in epithelial ovarian cancer
Jonathan Tammela, Akiko Uenaka, Toshiro Ono, Yuji Noguchi, Achim A. Jungbluth, Paulette Mhawech-Fauceglia, Feng Qian, Sally Schneider, Sameer Sharma, Deborah L. Drisco...> ;International Journal of Oncology. 2006 Oct 1
229 citations
Detection of epithelial ovarian cancer using 1H‐NMR‐based metabonomics
Kunle Odunsi, Robert M. Wollman, Christine B. Ambrosone, Alan D. Hutson, Susan E. McCann, Jonathan Tammela, John P. Geisler, Gregory Miller, Thomas A. Sellers, William...> ;International Journal of Cancer. 2005 Feb 20
18 citations
Efficacy of adjuvant CYVADIC chemotherapy in early-stage uterine sarcomas: results of long-term follow-up.
K. Odunsi, V. Moneke, Jonathan Tammela, Sharad A. Ghamande, P. Seago, Deborah L. Driscoll, David Marchetti, Trudy R. Baker, Sashikant Lele> ;International Journal of Gynecological Cancer. 2004 Jul 1
7 citations
Reassessment of pelvic lymph node debulking in advanced cervical cancer.
Jonathan Tammela, Brian N. Bundy, Kunle Odunsi> ;Gynecologic Oncology. 2004 Mar 1
19 citations
New modalities in detection of recurrent ovarian cancer.
Jonathan Tammela, Shashikant Lele> ;Current Opinion in Obstetrics & Gynecology. 2004 Feb 1
23 citations
SCP-1 cancer/testis antigen is a prognostic indicator and a candidate target for immunotherapy in epithelial ovarian cancer.
Jonathan Tammela, Achim A. Jungbluth, Feng Qian, Darren Santiago, Matthew J. Scanlan, Bernadette Keitz, Deborah L. Driscoll, Kerry J. Rodabaugh, Shashikant Lele, Lloyd...> ;Cancer Immunity. 2004 Jan 1
200 citations
NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.
Kunle Odunsi, Achim A. Jungbluth, Elisabeth Stockert, Feng Qian, Sacha Gnjatic, Jonathan Tammela, Marilyn Intengan, Amy Beck, Bernadette Keitz, Darren Santiago, Barbar...> ;Cancer Research. 2003 Sep 15
A human papillomavirus type 16 vaccine.
Simon S Yoo, S Elizabeth Whitmore> ;The New England Journal of Medicine. 2003 Apr 3
A human papillomavirus type 16 vaccine.
Carlo B Gambacorti> ;The New England Journal of Medicine. 2003 Apr 3
A human papillomavirus type 16 vaccine.
Stephanie J Schrag, Anne Schuchat, Jay Schulkin> ;The New England Journal of Medicine. 2003 Apr 3
A human papillomavirus type 16 vaccine.
Jonathan E Tammela, Shashikant Lele, Kunle Odunsi> ;The New England Journal of Medicine. 2003 Apr 3
30 citations
Heat Shock Protein 27: An Independent Prognostic Indicator of Survival in Patients with Epithelial Ovarian Carcinoma
John P. Geisler, Hans E. Geisler, Jonathan Tammela, M. C. Wiemann, Zhen Zhou, Greg A. Miller, William N. Crabtree> ;Gynecologic Oncology. 1998 Apr 1
Clear cell carcinoma of the ovary: poor prognosis compared to serous carcinoma.
Tammela, J., Geisler, J. P., Eskew, P. N., Geisler, H. E.> ;Eur J Gynaecol Oncol. 1998
Heat shock protein 27 in the placentas of women with and without severe preeclampsia.
Geisler, J. P., Manahan, K. J., Geisler, H. E., Tammela, J. E., Rose, S. L., Hiett, A. K., Miller, G. A., Wiemann, M. C., Zhou, Z.> ;Clin Exp Obstet Gynecol. 2004
A study of heat shock protein 27 in endometrial carcinoma.
Geisler, J. P., Geisler, H. E., Tammela, J., Miller, G. A., Wiemann, M. C., Zhou, Z.> ;Gynecol Oncol. 1999 Mar
HSP27 in patients with ovarian carcinoma: still an independent prognostic indicator at 60 months follow-up.
Geisler, J. P., Tammela, J. E., Manahan, K. J., Geisler, H. E., Miller, G. A., Zhou, Z., Wiemann, M. C.> ;Eur J Gynaecol Oncol. 2004
Gene expression and prognostic significance in ovarian cancer.
Tammela, J., Odunsi, K.> ;Minerva Ginecol. 2004 Dec
Join now to see all

Professional Memberships

American College of Obstetricians and Gynecologists
Fellow

Hospital Affiliations

Mercy Hospital DowntownBakersfield, California